{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-26-000990","form_type":"8-K/A","ticker":"SBEV","cik":"0001553788","company_name":"SPLASH BEVERAGE GROUP, INC.","filed_at":"2026-07-30T20:10:52+00:00","discovered_at":"2026-07-30T20:12:00.368817+00:00","generated_at":"2026-07-30T20:12:06.904406+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Splash Beverage expands CannEpil license to veterinary therapeutics; royalty 10% on vet revenue","bullets":["Expanded exclusive global license for CannEpil to include veterinary applications; royalty 10% of net revenue for vet, 15% for human.","Initial focus on companion-animal oncology and chronic pain management; canine indications expected first.","Global veterinary pain management market ~$2.6B in 2024, projected ~$3.8B by 2030; veterinary oncology market $900M-$1.7B.","Company finalizing strategic joint venture with established cannabinoid pharmaceutical company to lead vet development.","CannEpil is EU-GMP manufactured, has IND for human program; will pursue FDA Center for Veterinary Medicine pathways."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-000990","json":"https://secwatch.observer/filing/0001731122-26-000990.json","markdown":"https://secwatch.observer/filing/0001731122-26-000990.md","text":"https://secwatch.observer/filing/0001731122-26-000990.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000990/0001731122-26-000990-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1553788/000173112226000990/e7816_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-30T20:12:06.904406+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}